Changhui Xue

1.4k total citations
17 papers, 1.1k citations indexed

About

Changhui Xue is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Changhui Xue has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Changhui Xue's work include Cancer, Hypoxia, and Metabolism (6 papers), Hypothalamic control of reproductive hormones (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Changhui Xue is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Hypothalamic control of reproductive hormones (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Changhui Xue collaborates with scholars based in United States and China. Changhui Xue's co-authors include David Z. Qian, Hao Geng, Tomasz M. Beer, Qiong Liu, Oline K. Rønnekleiv, Martha A. Bosch, Martin J. Kelly, Chris T. Harvey, George Thomas and Janét Pittsenbarger and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Neuroscience.

In The Last Decade

Changhui Xue

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changhui Xue United States 14 588 263 134 129 123 17 1.1k
Nanao Horike Japan 24 977 1.7× 174 0.7× 144 1.1× 135 1.0× 87 0.7× 33 1.5k
Xun Zhou China 22 461 0.8× 101 0.4× 101 0.8× 72 0.6× 27 0.2× 79 1.3k
Weiqing Li China 16 864 1.5× 352 1.3× 89 0.7× 86 0.7× 241 2.0× 55 1.5k
Junko Doi Japan 17 703 1.2× 153 0.6× 99 0.7× 112 0.9× 90 0.7× 35 1.1k
Mei Zhou China 17 423 0.7× 97 0.4× 173 1.3× 137 1.1× 61 0.5× 37 950
Jeong Su Oh South Korea 25 1.3k 2.1× 202 0.8× 194 1.4× 206 1.6× 37 0.3× 68 2.2k
Koichiro Kako Japan 16 1.0k 1.8× 138 0.5× 85 0.6× 91 0.7× 326 2.7× 50 1.6k
Jinu Lee South Korea 19 1.1k 2.0× 330 1.3× 171 1.3× 201 1.6× 20 0.2× 64 1.8k
Hsu‐Wen Chao Taiwan 19 817 1.4× 119 0.5× 106 0.8× 107 0.8× 90 0.7× 37 1.3k
Yiyuan Yuan China 15 677 1.2× 268 1.0× 52 0.4× 56 0.4× 62 0.5× 30 1.1k

Countries citing papers authored by Changhui Xue

Since Specialization
Citations

This map shows the geographic impact of Changhui Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changhui Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changhui Xue more than expected).

Fields of papers citing papers by Changhui Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changhui Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changhui Xue. The network helps show where Changhui Xue may publish in the future.

Co-authorship network of co-authors of Changhui Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Changhui Xue. A scholar is included among the top collaborators of Changhui Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changhui Xue. Changhui Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Xue, Changhui, et al.. (2025). Understanding Enzalutamide‐Resistance Based on a Functional Single‐Cell Approach. The Prostate. 85(9). 888–899.
2.
Cheng, Larry C., Changhui Xue, Christopher W. Ryan, et al.. (2021). Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma. Cell Reports Medicine. 2(5). 100267–100267. 8 indexed citations
3.
Geng, Hao, Janét Pittsenbarger, Changhui Xue, et al.. (2021). HIF1 and ID1 Interplay Confers Adaptive Survival to HIF1α-Inhibition. Frontiers in Cell and Developmental Biology. 9. 724059–724059. 4 indexed citations
4.
Geng, Hao, Changhui Xue, Janet Mendonca, et al.. (2018). Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy. Nature Communications. 9(1). 4972–4972. 54 indexed citations
5.
Li, Bingbing X., Ryan T. Gardner, Changhui Xue, et al.. (2016). Systemic Inhibition of CREB is Well-tolerated in vivo. Scientific Reports. 6(1). 61 indexed citations
6.
Liu, Qiong, Hao Geng, Changhui Xue, Tomasz M. Beer, & David Z. Qian. (2015). Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(5). 881–891. 27 indexed citations
7.
Eide, Christopher A., Beth Wilmot, Changhui Xue, et al.. (2015). Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma. Oncotarget. 6(42). 44675–44687. 30 indexed citations
8.
Xie, Fuchun, Bingbing X. Li, Changhui Xue, et al.. (2015). Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity. Journal of Medicinal Chemistry. 58(12). 5075–5087. 127 indexed citations
9.
Qin, Xiaojie, et al.. (2014). Biocontrol of gray mold in grapes with the yeast Hanseniaspora uvarum alone and in combination with salicylic acid or sodium bicarbonate. Postharvest Biology and Technology. 100. 160–167. 117 indexed citations
10.
Liu, Qiong, Chris T. Harvey, Hao Geng, et al.. (2013). Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism. The Prostate. 73(10). 1028–1037. 55 indexed citations
11.
Geng, Hao, Qiong Liu, Changhui Xue, et al.. (2012). HIF1α Protein Stability Is Increased by Acetylation at Lysine 709. Journal of Biological Chemistry. 287(42). 35496–35505. 132 indexed citations
12.
Weiss, Joseph B., Changhui Xue, Ted S. Benice, et al.. (2011). Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase: Functions and genetic interactions in learning, memory and adult neurogenesis. Pharmacology Biochemistry and Behavior. 100(3). 566–574. 76 indexed citations
13.
Bosch, Martha A., Changhui Xue, & Oline K. Rønnekleiv. (2011). Kisspeptin expression in guinea pig hypothalamus: Effects of 17β‐estradiol. The Journal of Comparative Neurology. 520(10). 2143–2162. 37 indexed citations
14.
Geng, Hao, Chris T. Harvey, Janét Pittsenbarger, et al.. (2011). HDAC4 Protein Regulates HIF1α Protein Lysine Acetylation and Cancer Cell Response to Hypoxia. Journal of Biological Chemistry. 286(44). 38095–38102. 171 indexed citations
15.
Roepke, Troy A., Changhui Xue, Martha A. Bosch, et al.. (2008). Genes Associated with Membrane-Initiated Signaling of Estrogen and Energy Homeostasis. Endocrinology. 149(12). 6113–6124. 75 indexed citations
16.
Qiu, Jian, Changhui Xue, Martha A. Bosch, et al.. (2007). Serotonin 5-Hydroxytryptamine2C Receptor Signaling in Hypothalamic Proopiomelanocortin Neurons: Role in Energy Homeostasis in Females. Molecular Pharmacology. 72(4). 885–896. 68 indexed citations
17.
Qiu, Jian, et al.. (2006). Estrogen Upregulates T-Type Calcium Channels in the Hypothalamus and Pituitary. Journal of Neuroscience. 26(43). 11072–11082. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026